DnB Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Hold
33,886
0.04% 306
2026
Q1
$16M Buy
33,886
+1,949
+6% +$981K 0.06% 222
2025
Q4
$14.9M Sell
31,937
-2,023
-6% -$939K 0.05% 222
2025
Q3
$14.5M Buy
33,960
+246
+0.7% +$95.3K 0.05% 231
2025
Q2
$12.9M Buy
33,714
+705
+2% +$254K 0.05% 232
2025
Q1
$11.4M Sell
33,009
-542
-2% -$174K 0.05% 239
2024
Q4
$10.1M Sell
33,551
-29,000
-46% -$10.1M 0.04% 260
2024
Q3
$25.4M Sell
62,551
-21,666
-26% -$7.93M 0.11% 142
2024
Q2
$27.1M Buy
84,217
+27,200
+48% +$8.84M 0.13% 123
2024
Q1
$19M Sell
57,017
-3,665
-6% -$1.12M 0.1% 154
2023
Q4
$16.4M Buy
60,682
+7,476
+14% +$1.85M 0.09% 188
2023
Q3
$13.1M Buy
53,206
+8,158
+18% +$2.23M 0.08% 197
2023
Q2
$13.7M Buy
45,048
+6,978
+18% +$1.94M 0.08% 189
2023
Q1
$10M Sell
38,070
-2,262
-6% -$575K 0.06% 233
2022
Q4
$9.68M Sell
40,332
-910
-2% -$204K 0.07% 227
2022
Q3
$7.58M Sell
41,242
-1,778
-4% -$354K 0.06% 256
2022
Q2
$7.23M Sell
43,020
-253
-0.6% -$54.4K 0.05% 268
2022
Q1
$10.8M Sell
43,273
-17,075
-28% -$4.29M 0.06% 230
2021
Q4
$15.5M Buy
60,348
+607
+1% +$149K 0.09% 187
2021
Q3
$14.5M Buy
59,741
+17,447
+41% +$4.27M 0.09% 179
2021
Q2
$8.74M Buy
42,294
+2,326
+6% +$474K 0.06% 241
2021
Q1
$7.53M Buy
39,968
+5,332
+15% +$940K 0.05% 239
2020
Q4
$5.7M Buy
34,636
+616
+2% +$90.1K 0.05% 240
2020
Q3
$4.24M Buy
34,020
+1,572
+5% +$195K 0.05% 257
2020
Q2
$3.15M Buy
32,448
+2,397
+8% +$249K 0.04% 288
2020
Q1
$2.7M Sell
30,051
-6,838
-19% -$885K 0.04% 271
2019
Q4
$5.45M Sell
36,889
-16,581
-31% -$2.23M 0.05% 234
2019
Q3
$6.44M Buy
53,470
+2,120
+4% +$274K 0.07% 200
2019
Q2
$6.94M Buy
51,350
+10,907
+27% +$1.38M 0.08% 189
2019
Q1
$5.27M Sell
40,443
-4,204
-9% -$565K 0.06% 207
2018
Q4
$5.56M Buy
44,647
+8,290
+23% +$1.11M 0.07% 188
2018
Q3
$5.06M Buy
36,357
+413
+1% +$51.4K 0.06% 226
2018
Q2
$3.69M Buy
35,944
+1,900
+6% +$192K 0.04% 262
2018
Q1
$3.3M Buy
34,044
+1,200
+4% +$116K 0.04% 279
2017
Q4
$2.89M Hold
32,844
0.03% 296
2017
Q3
$2.61M Sell
32,844
-1,000
-3% -$80.4K 0.03% 288
2017
Q2
$2.95M Sell
33,844
-900
-3% -$76.1K 0.04% 259
2017
Q1
$3.09M Buy
34,744
+6,500
+23% +$542K 0.05% 256
2016
Q4
$2.09M Buy
28,244
+1,000
+4% +$74.9K 0.04% 270
2016
Q3
$2.06M Buy
27,244
+1,900
+7% +$145K 0.04% 272
2016
Q2
$1.95M Buy
25,344
+500
+2% +$39.5K 0.04% 267
2016
Q1
$1.94M Buy
24,844
+11,000
+79% +$768K 0.04% 260
2015
Q4
$936K Sell
13,844
-21,000
-60% -$1.46M 0.02% 327
2015
Q3
$2.7M Sell
34,844
-18,073
-34% -$1.6M 0.07% 185
2015
Q2
$4.8M Buy
52,917
+1,000
+2% +$80.1K 0.11% 149
2015
Q1
$3.91M Buy
51,917
+21,200
+69% +$1.52M 0.09% 167
2014
Q4
$2.25M Buy
30,717
+4,600
+18% +$323K 0.05% 214
2014
Q3
$1.84M Sell
26,117
-12,200
-32% -$806K 0.04% 225
2014
Q2
$2.16M Buy
+38,317
New +$2.02M 0.05% 217
2013
Q4
$1.44M Buy
30,117
+1,400
+5% +$64.7K 0.03% 205
2013
Q3
$1.23M Buy
28,717
+3,400
+13% +$133K 0.03% 228
2013
Q2
$913K Buy
+25,317
New +$979K 0.03% 267

Other funds holding HCA

DnB Asset Management's HCA Position: Q2 2026 in Review

DnB Asset Management held its HCA Healthcare (HCA) position steady in Q2 2026 at 33,886 shares worth $13.2M. The position accounts for 0.04% of the portfolio, ranked #306.

DnB Asset Management first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.1M in Q2 2024. 943 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • DnB Asset Management held 33,886 shares of HCA Healthcare worth $13.2M as of Q2 2026.
  • DnB Asset Management left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.04% of DnB Asset Management's portfolio in Q2 2026, its #306 holding.
  • DnB Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • DnB Asset Management's HCA Healthcare position peaked at $27.1M in Q2 2024.
  • 943 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.